Table 2.
Clinical and biochemical characteristics of PCOS women according to blood lipid states.
| Dyslipidemia group (n = 289) | Normal Lipid group (n = 411) | P | Pa | |
|---|---|---|---|---|
| Age | 24.22 ± 5.03 | 24.90 ± 4.45 | 0.064 | |
| BMI | 24.95 ± 5.05 | 24.60 ± 4.81 | 0.373 | |
| WC | 87.63 ± 13.15 | 86.55 ± 12.62 | 0.389 | 0.479 |
| F-G Score | 1.28 ± 1.34 | 1.03 ± 1.54 | 0.024 | 0.751 |
| FSH (mIU/ml) | 6.69 ± 1.51 | 7.09 ± 1.68 | 0.005 | 0.003* |
| LH (mIU/ml) | 12.57 ± 6.94 | 13.27 ± 7.28 | 0.226 | 0.320 |
| T (ng/ml) | 0.76 ± 0.27 | 0.82 ± 0.26 | 0.002 | 0.004* |
| SHBG (nmol/L) | 37.00 ± 29.79 | 42.11 ± 30.44 | 0.092 | 0.259 |
| AMH (ng/ml) | 9.38 ± 5.30 | 9.31 ± 4.53 | 0.888 | 0.448 |
| FAI | 3.41 ± 4.43 | 3.04 ± 2.43 | 0.297 | 0.584 |
| LH/FSH | 1.93 ± 1.08 | 1.91 ± 1.07 | 0.779 | 0.933 |
| OGTT (mmol/L) 0h | 5.03 ± 1.36 | 4.89 ± 0.75 | 0.109 | 0.208 |
| 0.5h | 8.48 ± 4.62 | 8.23 ± 1.45 | 0.391 | 0.696 |
| 1h | 8.55 ± 3.64 | 8.44 ± 2.36 | 0.632 | 0.959 |
| 2h | 6.88 ± 2.61 | 6.73 ± 2.10 | 0.396 | 0.386 |
| 3h | 6.68 ± 11.84 | 5.34 ± 6.53 | 0.089 | 0.075 |
| INR (uU/ml) 0h | 13.67 ± 8.64 | 12.05 ± 7.82 | 0.013 | 0.004* |
| 0.5h | 97.70 ± 63.67 | 92.12 ± 55.80 | 0.230 | 0.634 |
| 1h | 115.69 ± 72.99 | 108.42 ± 67.13 | 0.195 | 0.773 |
| 2h | 101.00 ± 74.48 | 90.79 ± 66.57 | 0.071 | 0.399 |
| 3h | 44.33 ± 49.71 | 36.48 ± 40.43 | 0.032 | 0.033* |
| HOMA-IR | 2.90 ± 1.94 | 2.56 ± 1.63 | 0.021 | 0.009* |
Values are shown as mean ± standard deviation. BMI, Body mass index; WC, waist circumference; F-G score, Ferriman–Gallwey score; FSH, Follicle stimulating hormone; LH, Luteinizing hormone; T, Testosterone; SHBG, Sex hormone-binding globulin; AMH, Anti-Mullerian hormone; FAI, Free androgen index; OGTT, Oral glucose tolerance test; IRT, Insulin release test; HOMA-IR, Homeostatic model assessment for insulin resistance. P a: adjusted age, BMI, and WC.
P*: The differences were considered significant.